It’s well-established that cell-free protein synthesis (CFPS) is a highly efficient way to produce complex therapeutic proteins and that vesicle delivery systems are very effective transport systems.

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...

Ebihara Takashi has been the chief operating officer of GeneFrontier (GFC) since 2010, with a focus on advancing cell-free protein expression technologies, particularly the PURE system. He earned a ...

Elegen’s ENFINIA™ Linear DNA offers high-accuracy, double-stranded DNA up to 7kb with 99.999% accuracy. Its cell-free synthesis eliminates cloning, delivering NGS-verified sequences in 6–8 business ...

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...